Improved heart function and reduced inflammatory cells in the heart after treatment with IFN-β, which lowered the risk of progression to dilated cardiomyopathy, where also observed in an additional study with Parvovirus B19-infected patients [51, 52]. This evidence concerns the gene IFNB1 and dilated cardiomyopathy.